go 6976 has been researched along with r 1530 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB | 1 |
Awrey, DE; Ban, F; Beletskaya, I; Edwards, L; Feher, M; Forrest, B; Green, E; Hodgson, R; Kiarash, R; Lang, Y; Laufer, R; Leung, G; Li, SW; Liu, Y; Luo, X; Mak, TW; Mao, G; Mason, JM; Pan, G; Pauls, HW; Plotnikova, O; Sampson, P; Wei, X; Yao, Y | 1 |
2 other study(ies) available for go 6976 and r 1530
Article | Year |
---|---|
Navigating the kinome.
Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology | 2011 |
The discovery of PLK4 inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as novel antiproliferative agents.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Indazoles; Indoles; Mice; Mice, SCID; Models, Molecular; Protein Serine-Threonine Kinases; Stereoisomerism; Structure-Activity Relationship; Transplantation, Heterologous | 2013 |